Email
Get the latest from The Australian Business Review
To view this email as a web page, go here.
The Australian Business Review
 

Good morning,

Australia must continue with its 2030 energy transition targets or risk missing out on large amounts of offshore capital that will provide an economic boost to regional communities, urges the boss of renewable energy giant Acciona Energia.

Meanwhile, one of the country's top regulatory experts says ASIC should be empowered by an “eat what you kill” model and take a slice of any fines and penalties it metes out, as part of any overhaul to improve the corporate cop's results. 

And the NBN Co is gearing up for the AI era , banking on the fact that the relatively new technology will spark increased demand for its fibre network as it recovers from an almost $1.2bn annual loss.

Perry Williams
Business editor
The markets


Making news this morning
1
US-based gaming supplier’s strategy for Aussie expansion
Las Vegas-based ASX-listed gaming supplier Light & Wonder plans to grow its Australian market share and investor base as it challenges Aristocrat’s longstanding dominance.
2
Medtech founder ’devastated’ about funding dispute
Medtech company Seer Medical’s co-founder says he is ‘devastated’ by the fallout of funding negotiations allegedly souring with Victoria’s venture capital fund.
3
EY focused on tech for growth amid revenue drop
The consulting giant says its government consulting business offers plenty of value despite facing softer demand, as it spells out how AI will drive the company to growth in the new year.
Editor's picks
TECHNOLOGY
Google is finally getting in the fold
The US tech giant is finally bringing its folding phone to Australia to crank up the competition with Samsung, Oppo and Microsoft.
By JOSEPH LAM
MARGIN CALL
Little to envy about the nation’s first anti-Semitism envoy
Spare a thought for newly minted anti-Semitism envoy Jillian Segal, who has to report her findings to the politically conflicted Tony Burke, whose electorate thinks Labor’s too soft on Israel.
By YONI BASHAN, NICK EVANS
Commentary
Why CSL doesn’t see itself as another big pharma
By ERIC JOHNSTON
Associate Editor
The homegrown drug company wants to be known as a smart manufacturer as much as for its role in helping to save lives.
Why renewables are an opportunity for regional Australia
By BRETT WICKHAM
Renewable energy is established and competitive alternatives are elusive, so we must recognise that this power source provides abundant opportunity to our regional areas.
Dataroom
Macquarie on ticket for Lone Star’s $3.4bn Orora bid
The US-based Lone Star swooped on Orora over a week ago after its $2.1bn acquisition of Saverglass last year.
Macquarie, Wesfarmers line up for $3bn I-MED sale
One of the biggest healthcare sale processes of the year is about to get going in the coming weeks.
Final bids set to land for Healius unit
Healius diagnostic imaging suitors are getting toward the end of the sale process.